Alzamend Neuro
ALZN
ALZN
14 hedge funds and large institutions have $335K invested in Alzamend Neuro in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
78% less capital invested
Capital invested by funds: $1.49M → $335K (-$1.16M)
Holders
14
Holding in Top 10
–
Calls
$79K
Puts
–
Top Buyers
| 1 | +$15K | |
| 2 | +$9.2K | |
| 3 | +$7.73K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.21K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$80 |
Top Sellers
| 1 | -$50.8K | |
| 2 | -$24.6K | |
| 3 | -$12.6K | |
| 4 |
Bank of New York Mellon
New York
|
-$9.57K |
| 5 |
IIC
Integrated Investment Consultants
Bloomfield Hills,
Michigan
|
-$9.48K |